Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy

被引：0
|
作者：
Hayashi, K. [1 ]
Ishigami, M. [1 ]
Ishizu, Y. [1 ]
Kazuya, T. [1 ]
Honda, T. [1 ]
Hirooka, Y. [1 ]
Goto, H. [1 ]
机构：
[1] Nagoya Univ, Gastroenterol & Hepatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30813-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-373
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] A novel fixed-dose combination treatment for chronic hepatitis C, based on NS5A inhibitor fopitasvir and NS5B inhibitor sofosbuvir
    Zhou, Shu-Yan
    Chen, Xin-Yi
    Chen, Yan
    Meng, Na-Na
    Tao, Xin
    He, Hua-Long
    Liu, Zhi-Hao
    Wang, Ning-Yu
    Yu, Luo-Ting
    PHARMAZIE, 2021, 76 (08): : 372 - 378
  • [42] Distribution of pre-existing NS5A/NS5B resistance associated variants in genotype 1b patients with hepatitis C virus and response to direct acting antivirals
    Watabe, Takeshi
    Korenaga, Masaaki
    Sugiyama, Masaya
    Kumagai, Erina
    Ueyama, Misuzu
    Aoki, Yoshihiko
    Yamagiwa, Yoko
    Korenaga, Keiko
    Imamura, Masatoshi
    Murata, Kazumoto
    Masaki, Naohiko
    Kanto, Tatsuya
    Mizokami, Masashi
    HEPATOLOGY, 2015, 62 : 1083A - 1083A
  • [43] Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins
    Ivanov, AV
    Korovina, AN
    Tunitskaya, VL
    Kostyuk, DA
    Rechinsky, VO
    Kukhanova, MK
    Kochetkov, SN
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 48 (01) : 14 - 23
  • [44] Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy
    Bertoli, Ada
    Sorbo, Maria Chiara
    Aragri, Marianna
    Lenci, Ilaria
    Teti, Elisabetta
    Polilli, Ennio
    Di Maio, Velia Chiara
    Gianserra, Laura
    Biliotti, Elisa
    Masetti, Chiara
    Magni, Carlo F.
    Babudieri, Sergio
    Nicolini, Laura A.
    Milana, Martina
    Cacciatore, Pierluigi
    Sarmati, Loredana
    Pellicelli, Adriano
    Paolucci, Stefania
    Craxi, Antonio
    Morisco, Filomena
    Palitti, Valeria Pace
    Siciliano, Massimo
    Coppola, Nicola
    Iapadre, Nerio
    Puoti, Massimo
    Rizzardini, Giuliano
    Taliani, Gloria
    Pasquazzi, Caterina
    Andreoni, Massimo
    Parruti, Giustino
    Angelico, Mario
    Perno, Carlo Federico
    Cento, Valeria
    Ceccherini-Silberstein, Francesca
    SCIENTIFIC REPORTS, 2018, 8
  • [45] National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing
    Ruggiero, T.
    Cento, V.
    Aragri, M.
    Arosio, M.
    Baldanti, F.
    Brunetto, M.
    Bruzzone, B.
    Boeri, E.
    Cavallone, D.
    Coppola, N.
    Di Stefano, M.
    Ghisetti, V.
    Callegaro, A. P.
    Capobianchi, M. R.
    Caudai, C.
    Cuomo, N.
    Galli, S.
    Galmozzi, E.
    Garbuglia, A. R.
    Gennari, W.
    Lai, A.
    Menzo, S.
    Micheli, V.
    Minosse, C.
    Monno, L.
    Paolucci, S.
    Pollicino, T.
    Raddi, A.
    Raffa, G.
    Raimondo, G.
    Sanguinetti, M.
    Sampaolo, M.
    Santangelo, R.
    Santantonio, T.
    Soldini, S.
    Starace, M.
    Vatteroni, M. L.
    Craxi, A.
    Perno, C. F.
    Ceccherini-Silberstein, F.
    Zazzi, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 55 - 56
  • [46] National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing
    Ruggiero, T.
    Cento, V.
    Aragri, M.
    Arosio, M.
    Baldanti, F.
    Brunetto, M.
    Bruzzone, B.
    Boeri, E.
    Cavallone, D.
    Nicola, C.
    Stefano, M. A. D.
    Ghisetti, V.
    Callegaro, M. P.
    Capobianchi, M. R.
    Caudai, C.
    Cuomo, N.
    Galli, S.
    Galmozzi, E.
    Garbuglia, A.
    Gennari, W.
    Lai, A.
    Menzo, S.
    Micheli, V.
    Minosse, C.
    Monno, L.
    Paolucci, S.
    Pollicino, T.
    Raddi, A.
    Raffa, G.
    Raimondo, G.
    Sanguinetti, M.
    Santangelo, R.
    Santantonio, T.
    Soldini, S.
    Starace, M.
    Vatteroni, M. L.
    Craxi, A.
    Perno, C. F.
    Silberstein, F. C.
    Zazzi, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S290 - S291
  • [47] Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon/Ribavirin Therapy
    Kawasaki, Saori
    Ho, Tu Bao
    Kanda, Tatsuo
    Yokosuka, Osamu
    Takabayashi, Katsuhiro
    Le, Nhan
    KNOWLEDGE, INFORMATION, AND CREATIVITY SUPPORT SYSTEMS, 2011, 6746 : 79 - +
  • [48] NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B
    Bessa, Luiza M.
    Launay, Helene
    Dujardin, Marie
    Cantrelle, Francois-Xavier
    Lippens, Guy
    Landrieu, Isabelle
    Schneider, Robert
    Hanoulle, Xavier
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (44) : 18024 - 18043
  • [49] Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance
    Hill, Deanna D.
    Kramer, Jennifer R.
    Chaffin, Kassie R.
    Mast, T. Christopher
    Robertson, Michael N.
    Kanwal, Fasiha
    Haber, Barbara A.
    ANNALS OF HEPATOLOGY, 2023, 28 (02)
  • [50] Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
    Shi, Niu
    Hiraga, Nobuhiko
    Imamura, Michio
    Hayes, C. Nelson
    Zhang, Yizhou
    Kosaka, Keiichi
    Okazaki, Akihito
    Murakami, Eisuke
    Tsuge, Masataka
    Abe, Hiromi
    Aikata, Hiroshi
    Takahashi, Shoichi
    Ochi, Hidenori
    Tateno-Mukaidani, Chise
    Yoshizato, Katsutoshi
    Matsui, Hirotaka
    Kanai, Akinori
    Inaba, Toshiya
    McPhee, Fiona
    Gao, Min
    Chayama, Kazuaki
    GUT, 2013, 62 (07) : 1055 - 1061
12345